MSB 1.95% $1.05 mesoblast limited

Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial, page-7

  1. 15,342 Posts.
    lightbulb Created with Sketch. 5489
    I did say yesterday I could smell an announcement coming today .... one of a few we will see over the month of April IMO ..... another night of restless sleep for @The Yankee coming up ... hehe

    Strong comments by both parties :

    Mesoblast Chief Executive Dr Silviu Itescu stated: “This significant public-private partnership is a prime example of how the combined resources of industry and government can be leveraged to evaluate in a most efficient and rigorous manner the potential of innovative therapies to make a meaningful difference to patient outcomes.”

    CTSN Chairman Dr A. Marc Gillinov said: “We are excited to work with Mesoblast to make a real impact on the high mortality associated with COVID-19. This randomized controlled trial is in line with our mandate to rigorously evaluate novel therapies for public health imperatives.”

    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.020(1.95%)
Mkt cap ! $1.193B
Open High Low Value Volume
$1.02 $1.07 $1.02 $7.487M 7.196M

Buyers (Bids)

No. Vol. Price($)
4 39700 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.05 86509 6
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
$1.05
  Change
0.020 ( 1.89 %)
Open High Low Volume
$1.02 $1.07 $1.02 1379563
Last updated 15.59pm 07/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.